EUVIMEDEUVIMED entdecken
Crossref

Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets; CBP SL): Efficacy and Safety Analyses of CBP SL 2.8 mg and 5.6 mg in Adults with Fibromyalgia

Srinivas Nalamachu, Errol Gould, Benjamin Vaughn, Jean Heilman, Greg Sullivan

PM&R · 2026-11 · 18 (S3)

DOI: 10.1002/pmrj.225_70259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Srinivas Nalamachu und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nalamachu, S., Gould, E., Vaughn, B., Heilman, J., & Sullivan, G. (2026). Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets; CBP SL): Efficacy and Safety Analyses of CBP SL 2.8 mg and 5.6 mg in Adults with Fibromyalgia. PM&R, 18(S3). https://doi.org/10.1002/pmrj.225_70259

Vancouver

Nalamachu S, Gould E, Vaughn B, Heilman J, Sullivan G. Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets; CBP SL): Efficacy and Safety Analyses of CBP SL 2.8 mg and 5.6 mg in Adults with Fibromyalgia. PM&R. 2026;18(S3). doi:10.1002/pmrj.225_70259

BibTeX
@article{Nalamachu2026,
  author = {Nalamachu, Srinivas and Gould, Errol and Vaughn, Benjamin and Heilman, Jean and Sullivan, Greg},
  title = {Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets; CBP SL): Efficacy and Safety Analyses of CBP SL 2.8 mg and 5.6 mg in Adults with Fibromyalgia},
  journal = {PM&R},
  year = {2026},
  volume = {18},
  number = {S3},
  doi = {10.1002/pmrj.225_70259}
}
Kostenlos starten →